Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ABLIM2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ABRACL | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | AC003002.6 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | AC003006.7 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | AC006449.2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | AC006486.9 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
mRNA | AC008522.1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | AC009065.1 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |